Faculty of Medicine, Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.
Department of Clinical Pharmacy and Pharmacology, QPS-NL, The University Medical Center, University of Groningen, Groningen, the Netherlands.
Clin Exp Allergy. 2017 Dec;47(12):1555-1565. doi: 10.1111/cea.13036. Epub 2017 Oct 9.
Allergy and asthma are closely linked. Inhalation of allergen induces an early allergic response (EAR) within the airways of allergic asthmatic subjects, which is followed by a late allergic response (LAR) in approximately 50% of the subjects. The LAR is defined as a drop in forced expiratory volume in 1 second (FEV ) from baseline usually occurring 4-8 hours after exposure and is believed to affect small airways. However, FEV is insensitive to changes in small airway physiology.
Our aim was to investigate and compare the pathophysiological processes in large and small airways during the EAR and the LAR and to characterize subjects with both an EAR and a LAR (dual responders) versus those with an EAR only (single responders).
Thirty-four subjects with allergic asthma underwent an inhaled allergen challenge. Lung physiology was assessed by spirometry, impulse oscillometry (IOS), body plethysmography, inert gas washout, single breath methane dilution carbon monoxide diffusion and exhaled breath temperature (EBT), at baseline and repeatedly for 23 hours post-allergen challenge.
Peripheral airway resistance, air trapping and ventilation heterogeneity were significantly increased in dual responders (n = 15) compared to single responders (n = 19) 6-8 hours post-challenge. Parameters of peripheral airway resistance and ventilation heterogeneity, measured with IOS and inert gas washout, respectively, correlated at baseline and during the allergic airway response in all subjects.
The LAR involves increased resistance and ventilation defects within the peripheral airways. Alternative definitions of the LAR including small airways pathophysiology could be considered.
Small airway dysfunction during the LAR suggests that dual responders may have more extensive airway pathology and underscores the relevance of small airways assessment in asthma.
过敏和哮喘密切相关。过敏原吸入会在过敏性哮喘患者的气道中引起早期过敏反应 (EAR),随后约 50%的患者会出现晚期过敏反应 (LAR)。LAR 定义为用力呼气量 (FEV) 从基线下降,通常在暴露后 4-8 小时发生,被认为会影响小气道。然而,FEV 对小气道生理学变化不敏感。
我们旨在研究和比较 EAR 和 LAR 期间大气道和小气道的病理生理过程,并对同时具有 EAR 和 LAR 的患者(双重反应者)与仅具有 EAR 的患者(单一反应者)进行比较。
34 例过敏性哮喘患者接受吸入过敏原挑战。在基线和过敏原挑战后 23 小时内,通过肺活量测定法、脉冲振荡法 (IOS)、体描法、惰性气体洗脱、单口气溶胶甲烷稀释一氧化碳扩散和呼气温度 (EBT) 反复评估肺生理学。
与单一反应者 (n = 19) 相比,双反应者 (n = 15) 在挑战后 6-8 小时外周气道阻力、空气潴留和通气异质性显著增加。在所有受试者中,使用 IOS 和惰性气体洗脱分别测量的外周气道阻力和通气异质性参数在基线和过敏气道反应期间相关。
LAR 涉及外周气道阻力和通气缺陷增加。可以考虑包括小气道病理生理学在内的 LAR 的替代定义。
LAR 期间小气道功能障碍表明双重反应者可能具有更广泛的气道病理,突出了在哮喘中评估小气道的相关性。